7/2026

CH KILGER CITED IN LAW360

After winning in the first instance Munich LG I Patent Vindication Law Suit LAW360 picks up on the story and mentions CH KILGER as the law firm representing the winning Defendant. At the time the decision was still appealable.

Read more

6/2026

CH KILGER WINS IN DERIVATION LAWSUIT
BEFORE THE MUNICH DISTRICT COURT I
PROTEIN SEQUENCING LAWSUIT 44 O 10621/22 OVER
EP 3270139 B1 IS DISMISSED

The ability to sequence proteins has huge scientific and even more so diagnostic potential – it is a billion EURO market. While sequencing DNA has now become common place, the sequencing of proteins is still in its infancy.

Read more

1/2026

PATENTS AND TRADEMARKS IN BIOTECH & PHARMA

Intellectual Property for Researchers, Inventors and Founders

When? Friday, 6 February 2026 Read more

1/2026

From Ancient DNA to Global Courtrooms:
The Unlikely Journey of Dr. Christian Kilger

Read more ›

6/2025

CH KILGER at BIO USA in BOSTON

CH KILGER will be at BIO USA in BOSTON.

See us at booth #2865 and contact us for beers.

Read more

2/2025

CH KILGER wins EPO APPEAL

EPO REVOKES SINGLE CELL BARCODING PATENT EP 2 625 320 B1

Representing an undisclosed client, CH KILGER attacked the EUROPEAN PATENT EP 2 625 320 B1 in an Opposition before the European Patent Office in December of 2019.

Read more

3/2024

CH KILGER wins twice in EPO Board of Appeal Proceedings

EPO revokes two more DNA-sequencing patents despite Illumina appeal.

The EPO Boards of Appeal have confirmed the revocation of two more Illumina patents concerning DNA-sequencing technology. The same boards also issued a negative preliminary opinion concerning a third patent held by the US manufacturer of genetic engineering equipment.

Read more